Zeneca sues Eli Lilly over Evista promotion

Article Abstract:

Zeneca Group PLC has filed suit against Eli Lilly & Co. in federal court over Lilly's marketing of Evista, its drug that has FDA approval for treating osteoporosis only, not breast cancer. Lilly sales reps allegedly promote only safety data when telling physicians about its MORE trial in which Evista appeared to have similar effects on breast cancer as Zeneca's Nolvadex but without as many side effects.

Comment:

Zeneca suing to stop company from promoting Evista for breast cancer

Drugs, Anticancer Drugs, Care and treatment, Investigations, Antineoplastic agents, Osteoporosis, United States. Food and Drug Administration, Zeneca Group PLC

---

Lilly, in coup, settles for only $4 million portion of patent challenge to Prozac

Article Abstract:

The maker of $3-billion-a-year Prozac, Eli Lilly & Co. has won the right to keep making and selling the anti-depressant for another one to two years by settling for a mere $4 million. The settlement gives the Indiana-based firm time to develop a different anti-depressant and to keep working on other drugs to keep the revenue stream flowing.

Comment:

Co. settles part of patent suit brought by generics

Antidepressant Preparations, Antidepressants

---

Similar abstracts:

• Abstracts: 4 drug makers move to settle in pricing suit. Old drugs, new labels. American Home Products buying Monsanto for $34.4 billion
• Abstracts: 4 drug makers move to settle in pricing suit. Drug maker to close plants and cut jobs
• Abstracts: Northwest affiliate agrees to comply with US order to reinstate service. UAL girds for vote on unionization of ticket agents
• Abstracts: Hayes Corp. ties Chapter 11 filing to tumbling sales. AMR's 2nd-quarter profit jumps 35%, but results prompt a sell-off of stock
• Abstracts: Cisco tops $100 billion in market capital. Hewlett-Packard to reduce payroll in buyout program

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.